Investment
Features
FeesSafety
Academy
More
Pluang+

LB Pharmaceuticals to present at multiple investor conferences in Oct-Nov 2026

Market News
15 Oct 2026
GlobeNewsWire
View Source
Neutral
LB Pharmaceuticals to present at multiple investor conferences in Oct-Nov 2026

LB Pharmaceuticals Inc announced that its executive team will participate in several upcoming investor events, including virtual and in-person presentations and meetings from October to November 2026. These events include the Craig-Hallum Biotech Catalyst Conference, Guggenheim Securities Healthcare Innovation Conference, Wolfe Research Healthcare Conference, and Stifel Healthcare Conference. The company focuses on developing therapies for underserved brain disorders, with its lead candidate LB-102 aiming to be the first benzamide antipsychotic approved in the U.S. These presentations will provide updates on their pipeline and clinical progress, accessible via webcast on their investor website.

LB Pharmaceuticals' upcoming investor events coincide with a strong health sector showing on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 16, 2026 03:21 WIB: out of 150 priced US health-sector stocks, 128 rose and 21 fell. Notable movers include ALMS at USD 6.33 with a 1-day change of +4.46%, VTRS at USD 18.20 with +4.36%, and NUWE at USD 0.55 with +4.34% and a Pluang order activity split of 51% Sell / 49% Buy, with typical hold times ranging from 1 to 57 days.

More News

HDFC Bank to report earnings Oct 17; faces class action lawsuit over shares sold 2023-2026

HDFC Bank to report earnings Oct 17; faces class action lawsuit over shares sold 2023-2026

HDFC Bank is set to announce its quarterly earnings on October 17, 2026, with analysts expecting $0.40 earnings per share and $4.92 billion in revenue. The bank's valuation shows a trailing earnings multiple of 14.45x and a debt-to-equity ratio of 0....

Company Fundamentals
Neutral
28 minutes ago
Kohl's insider sells 18,352 shares amid mixed market views on stock's future.

Kohl's insider sells 18,352 shares amid mixed market views on stock's future.

Kohl's Chief Legal and Corporate Affairs Officer Jennifer J. Kent sold 18,352 shares for $403,744 on October 15, 2026, reducing her stake to 211,512 shares. Market opinions on Kohl's stock are divided, with some analysts expecting a decline while oth...

Market News
Neutral
1 hour ago
ManpowerGroup posts mixed Q3 results and announces new CEO for 2027

ManpowerGroup posts mixed Q3 results and announces new CEO for 2027

ManpowerGroup reported Q3 2026 revenue of $4.84 billion, slightly below estimates, with adjusted earnings per share at $1.01 matching expectations. Revenue grew 4% year-over-year, driven by strong U.S. Manpower and improving Experis segments. The com...

Company Fundamentals
Neutral
1 hour ago
Copper explorers in British Columbia use electrical surveys to identify promising drill targets amid rising copper prices.

Copper explorers in British Columbia use electrical surveys to identify promising drill targets amid rising copper prices.

Copper exploration in British Columbia is increasingly relying on induced polarization (IP) geophysical surveys, which measure electrical chargeability and resistivity in rocks to identify sulphide mineralization associated with copper deposits. Gold...

Market News
Bullish
1 hour ago
S&P 500 rises 30.6% in first 20 months of Trump's second term, nearing first term gains.

S&P 500 rises 30.6% in first 20 months of Trump's second term, nearing first term gains.

The S&P 500 index has increased by 30.6% during the first 20 months of Donald Trump's second presidential term, slightly surpassing the 28.5% gain recorded in the same period of his first term. This comparison is significant for investors as it provi...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App